Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0000899243-19-018352

Options or other derivatives

  • Director acquired 11,645 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sandoval Elisabeth · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-06-25 Grant or award : show line 1 in the form Stock Option +11,645 $6.02 2029-03-19 11,645 45,000 D
Loading xslF345X03/doc4.xml…